Cardiovascular disease (CVD) is the leading cause of death in the world, with a high
incidence and a youth-oriented tendency. RNA modification is ubiquitous and indispensable …

Cardiovascular disease (CVD) continues to impose a significant global health burden,
necessitating the exploration of innovative treatment strategies. Ribonucleic acid (RNA) …

More than one hundred RNA modifications decorate the chemical and topological properties
of these ribose nucleotides, thereby executing their biological functions through post …

Cardiovascular disease (CVD) remains the leading cause of death in the Western world.
Despite advances in the prevention and in the management of CVD, the role of RNA …

RNA is not always a faithful copy of DNA. Advances in tools enabling the interrogation of the
exact RNA sequence have permitted revision of how genetic information is transferred. We …

RNA epigenetics is perhaps the most recent field of interest for translational epigeneticists.
RNA modifications create such an extensive network of epigenetically driven combinations …

RNA therapeutics is a rapidly emerging field of biotherapeutics based upon a powerful and
versatile platform with a nearly unlimited capacity to address unmet clinical needs. These …

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide that
bears an enormous healthcare burden and aging is a major contributing factor to CVDs …

Cardiovascular diseases are the leading cause of death globally and are associated with
increasing financial expenditure. With the availability of next-generation sequencing …

Epigenetic gene regulations can be considered as de-novo initiation of abnormal molecular
signaling events whose regulation is otherwise required during normal or specific …